Daniel Kiser is listed as a director on 1 SEC Form D filing by 1 issuer in Nov 2013: REGENXBIO Inc. (Rockville, MD — biotechnology — 2013; $70.5M reported sold to 36 investors).
What this means One deal on file with the SEC, filed Nov 2013. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Allan M. Fox (1 shared filing), Don Hayden (1 shared filing) and Kenneth T. Mills (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 10 bankruptcy cases matching the name listed in Key records below.
What this means 10 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Daniel Kiser and found 1 difference, 1 worth asking the sponsor about: Bankruptcy case: Daniel J. Kiser and Kandyce K. Kiser.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.